Locus Fermentation Solutions, a U.S.-based biotechnology company producing performance-enhancing bio-based additives, announced the close of an oversubscribed $20 million investment in a convertible note round at an equity valuation of $100M led by Hudson Bay Capital, with the opportunity to up-size the round.

美国生物技术公司Locus Fermentation Solutions生产性能增强的生物基添加剂，宣布在Hudson Bay Capital领投的一轮可转换票据融资中，以1亿美元的股权估值成功完成了一笔超额认购的2000万美元投资，并有机会扩大融资规模。

The capital will be used to expand the company's domestic biomanufacturing capacity, accelerate commercial activities and product development across four strategic sectors: oil & gas, mining, agriculture, and industrial/CPG formulations. This latest round brings total funding this year to over $40 million in growth capital and includes participation from company leadership..

这笔资金将用于扩大公司的国内生物制造能力，加速在石油和天然气、矿业、农业以及工业/消费品配方这四个战略领域的商业活动和产品开发。此轮融资使得公司今年的总融资额超过4000万美元，并且公司领导层也参与其中。